LIN281632 OPTIONS

Contraindicated (one)bortezomib will improve the level or effect of mavacamten by affecting hepatic enzyme CYP2C19 metabolism. Contraindicated. Powerful or moderate CYP2C19 inhibitors may well raise mavacamten systemic publicity, leading to heart failure resulting from systolic dysfunction.Significant: The drug info on this web site is supposed to